Monday, December 27, 2021

What is ovarian cancer?

Overview about - Ovarian cancer refers to any cancerous growth that begins in the ovary. This is the part of the female body that produces eggs.

Ovarian cancer is now the fifth most common cause of cancer-related death among females in the United States. That said, deaths from ovarian cancer have been falling in the U.S. over the past 2 decades, according to the American Cancer Society Trusted Source (ACS).

The ACS estimate that in 2019, around 22,530 people may receive a diagnosis of ovarian cancer. Around 13,980 people are likely to die from this condition.

Alleviare Life sciences Pvt. Ltd. is a Pharma Consulting Companies specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

Read on to find out more about how to recognize the symptoms and what to expect if they occur.

Symptoms

Abdominal pain can be a symptom of ovarian cancer.

Most ovarian cancers start in the epithelium, or outer lining, of the ovary. In the early stages, there may be few or no symptoms.

If symptoms do occur, they can resemble those of other conditions, such as premenstrual syndrome, irritable bowel syndrome, or a temporary bladder problem. However, in ovarian cancer, the symptoms will persist and worsen.

Early symptoms may includeTrusted Source:

  • pain or pressure in the pelvis
  • unexpected vaginal bleeding
  • pain in the back or abdomen
  • bloating
  • feeling full rapidly when eating
  • changes in urination patterns, such as more frequent urination
  • changes in bowel habits, such as constipation

If any of these symptoms last for 2 weeks or more, a person should see a doctor.

There may also be:

  • nausea and indigestion
  • appetite loss
  • weight loss
  • breathlessness
  • fatigue
The maintenance treatment of adults with ovarian cancer, fallopian tube, primary peritoneal cancer whose cancer has come back and who are in response (complete or partial response) to a platinum-based chemotherapies. RUBRACA (RUCAPARIB) 300 MG TABLETS is used to treatment to Ovarian Cancer


No comments:

Post a Comment